{"id":2999,"date":"2013-10-23T15:13:52","date_gmt":"2013-10-23T15:13:52","guid":{"rendered":"\/?p=2999"},"modified":"2013-10-23T15:15:29","modified_gmt":"2013-10-23T15:15:29","slug":"biozone-pharmaceuticals-inc-otcbbbzne-makes-another-sliding-week","status":"publish","type":"post","link":"\/articles\/biozone-pharmaceuticals-inc-otcbbbzne-makes-another-sliding-week\/","title":{"rendered":"Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) Makes Another Sliding Week"},"content":{"rendered":"

Still too early to say, but Biozone Pharmaceuticals, Inc. (OTCBB:BZNE<\/a>) is not making a happy picture, charting another week in the red. On Tuesday, BZNE<\/a> lost a further 9.9% to touch 68 cents, on selling volumes of $1.18 million. Since last week, BZNE<\/a> gave signs that large-investor selling was almost over. But there is still not an exuberant takeoff. \"BZNE1023.png\" <\/p>\n

The mood on message boards is not only subdued but downright pessimistic, expecting a break below 60 cents. Still, there is some hope that the selling is still low-volume, before BZNE<\/a> is dialed in right and manages a sustainable climb. \"ISCO1023.png\"<\/p>\n

All of this may be temporary, but it puts a question on the logic that may support the company. BZNE<\/a> has secured investments through a non-toxic warrant sale, and has a technology that is widely used in the cosmetic sector, with viable options to employ it in food supplements. QuSomes is yet to prove itself as a remarkable source of revenues, and one has to wait and see how much publicity BZNE<\/a> needs in order to take off.<\/p>\n

If you want a similar caliber stock on a run, you can stop for AP Pharma, Inc. (OTCBB:APPA<\/a>), which is again trying to stay above 40 cents, and perhaps repeat the peaks from last months. Although buying is still thin, APPA<\/a> managed to open at 43 cents, with a positive mood early in the day.<\/p>\n

For International Stem Cell, Co. (OTCMKTS:ISCO<\/a>) the climb was also short-lived, not beyond the noisiest days of interest. ISCO<\/a> peaked around 22 cents, and made a red series toward 17 cents.<\/p>\n

BZNE<\/a> disappointed investors on forums, which expected the upward swing to come sooner, and some realized profits at the recent peak. There was not enough optimism to turn the trends mid-week, and now BZNE<\/a> has also the pre-weekend tradin\"APPA1023.png\"g to face.<\/p>\n

While pharmaceutical stocks are often capable of wild runs, these don’t come on short order. Sometimes, a company takes long months to gain enough momentum. And with only 70 million shares outstanding, a comparatively low amount, BZNE<\/a> may not have enough of an outreach to harness a wave of interest.<\/p>\n

If you still believe the fallout is the path to a bargain price, and that BZNE<\/a> would not fall below 40 cents due to the protective effect of the warrants, it is still best not to expect too much of a positive outcome. We will be tracking BZNE<\/a> to see if it will continue to test investors’ nerve.<\/p>\n","protected":false},"excerpt":{"rendered":"

Still too early to say, but Biozone Pharmaceuticals, Inc. (OTCBB:BZNE) is not making a happy picture, charting another week in the red. On Tuesday, BZNE lost a further 9.9% to touch 68 cents, on...<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[41,1022,238],"class_list":["post-2999","post","type-post","status-publish","format-standard","hentry","category-news","tag-appa","tag-bzne","tag-isco"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=2999"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/2999\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=2999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=2999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=2999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}